SCHEMBL4920127

SCHEMBL4920127

Cc1nn(C)cc1C(=O)Nc1ccccc1-c1cc(Cl)cc(Cl)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.61
SSTR2 P30874 1/20 0.57
SMN1; SMN2 Q16637 2/20 0.49
NAMPT P43490 1/20 0.48
CHRM3 P20309 4/20 0.48
MAPT P10636 3/20 0.47
ALDH1A1 P00352 3/20 0.47
GAA P10253 2/20 0.47
RAB9A P51151 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
NPC1 O15118 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.44
HTT P42858 1/20 0.44
JAK2 O60674 3/20 0.43
JAK1 P23458 1/20 0.43
EGFR P00533 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4157143 0.91 ATM (0.59) ATMSSTR2SMN1; SMN2NAMPTCHRM3
SCHEMBL646511 0.89 ATM (0.62) ATMSSTR2SMN1; SMN2NAMPTCHRM3
SCHEMBL4913313 0.88 SSTR2 (0.48) ATMSSTR2CHRM3MAPTALDH1A1
SCHEMBL1085423 0.87 ATM (0.68) ATMSMN1; SMN2NAMPTMAPTALDH1A1
SCHEMBL4915607 0.86 ATM (0.59) ATMSSTR2SMN1; SMN2NAMPTCHRM3
SCHEMBL2341630 0.86 ATM (0.56) ATMSSTR2SMN1; SMN2NAMPTCHRM3
SCHEMBL1134833 0.85 ATM (0.60) ATMSSTR2SMN1; SMN2NAMPTCHRM3
SCHEMBL304216 0.84 SSTR2 (0.45) ATMSSTR2CHRM3MAPTALDH1A1
SCHEMBL302840 0.84 LMNA (0.60) ATMSSTR2CHRM3TDP1LMNA
SCHEMBL4920642 0.84 ATM (0.59) ATMSSTR2SMN1; SMN2NAMPTCHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080153707-A1 Pyrazolecarboxanilides, Process for Their Preparation and Compositions Comprising Them for Controlling Harmful Fungi BASF AKITENGESELLSCHAFT (DE) 2008-06-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153707-A1 Pyrazolecarboxanilides, Process for Their Preparation and Compositions Comprising Them for Controlling Harmful Fungi CBR3, C1S, PYM1 ATM 2473/4885SSTR2 2379/4885SMN1; SMN2 4329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.